ストックスクリーナーアプリを入手
7.51
3.10%
-0.24
前日終値:
$7.75
開ける：
$7.75
24時間の取引高:
4,739
Relative Volume:
0.28
時価総額：
$6.11M
収益：
$43.86M
当期純損益:
$-37.43M
株価収益率:
-3.723
EPS:
-2.0172
ネットキャッシュフロー:
$-12.50M
1週間 パフォーマンス:
-5.30%
1か月 パフォーマンス:
+1.49%
6か月 パフォーマンス:
-64.49%
1年 パフォーマンス:
-72.19%
1日の値動き範囲:
$7.51
$7.9566
1週間の範囲:
$7.3705
$8.7657
52週間の値動き範囲:
$5.01
$52.50
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Compare TRIB vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
7.51 | 6.11M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-10-23 | ダウングレード | Craig Hallum | Buy → Hold |
| 2015-09-03 | 開始されました | Raymond James | Outperform |
| 2015-07-29 | 繰り返されました | ROTH Capital | Buy |
| 2008-07-22 | 繰り返されました | Roth Capital | Buy |
| 2008-03-17 | 繰り返されました | Roth Capital | Buy |
| 2007-12-10 | 繰り返されました | Roth Capital | Buy |
| 2007-10-26 | 繰り返されました | Roth Capital | Buy |
すべてを表示
Trinity Biotech Plc Adr (TRIB) 最新ニュース
Return on invested capital % of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Trinity Biotech reported 95 percent AGM support for Trinity Biotech stock - ad-hoc-news.de
TRIB Stock Price, Quote & News - Syfe
Total revenue of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Total debt of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Trinity Biotech Reports Unanimous Shareholder Approval at 2026 AGM - Kalkine Media
All resolutions passed as Trinity Biotech (TRIB) shareholders reappointed a director. - Stock Titan
Trinity Biotech stock gained 21.32 percent on October 5, 2026 - AD HOC NEWS
EBITDA of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0 - TradingView
Trinity Biotech stock slips after AI cooling contract rally, trades near 52-week low - AD HOC NEWS
Trinity Biotech stock slips after AI cooling contract rally, trades near 52-week low - AD HOC NEWS
Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players - Yahoo Finance
Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update - 富途牛牛
Trinity Biotech (NASDAQ: TRIB) tests AI data center liquid cooling in new U.S. pilot deal - Stock Titan
A paid pilot will test Trinity Biotech cooling fluids in AI data centers - Stock Titan
Trinity Biotech Files 2025 Annual Report and AGM Materials with SEC - The Globe and Mail
Shareholders of Trinity Biotech (NASDAQ: TRIB) face key 2026 AGM votes - Stock Titan
Trinity Biotech plcADR Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
TRINITY BIOTECH PLC SEC Filing (Sep 2, 2026) - Stock Titan
Trinity Biotech plcADR Peer Comparison – Compare with Others - valueresearchonline.com
Trinity Biotech plcADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Trinity Biotech expands PrePsia patent portfolio to nine patents - Investing.com
Trinity Biotech expands PrePsia patent portfolio to nine patents By Investing.com - Investing.com India
Trinity Biotech plcADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Trinity Biotech (NASDAQ: TRIB) moves to keep Nasdaq listing - Stock Titan
Trinity Biotech (TRIB) pulls 675M unsold shares from $25M standby deal - Stock Titan
Trinity Biotech Updates on Commercial Progress, Manufacturing Transformation, PrePsia Patent Expansion and Nasdaq Compliance - Quiver Quantitative
Trinity Biotech Could Lose Its Nasdaq Listing After Missing a $15M Test - Stock Titan
Trinity Biotech Updates on Commercial Progress, Manufacturing Transformation, PrePsia Patent Expansion and Nasdaq Compliance - Quiver Quantitative
Trinity Biotech (NASDAQ: TRIB) ends $25M standby share deal - Stock Titan
Echelon’s More Than 700 MW in Development Gets a Cooling Collaborator - Stock Titan
Trinity Biotech (TRIB) makes AI data-center cooling push - Stock Titan
Trinity Biotech’s Trinovium Subsidiary Agrees to Collaborate with Echelon Data Centres to Develop Advanced Liquid Cooling Solutions for AI Infrastructure - The Manila Times
Trinity Biotech secures $7m from Perceptive Advisors - Investing.com
Trinity Biotech Secures Additional $7 Million Investment from Perceptive Advisors and Regains Nasdaq Bid Price Compliance - quiverquant.com
Trinity Biotech Regains Nasdaq Compliance After 10 Days at $1 or More - Stock Titan
Trinity Biotech Secures Additional $7 Million Investment from Perceptive Advisors and Regains Nasdaq Bid Price Compliance - Quiver Quantitative
Trinity Biotech Gets $7 Million Investment From Perceptive Advisors - Yahoo Finance
TRIB,ZBRA Volatility & Greeks - Finviz
Trinity Biotech plc Sponsored ADR Revenue Breakdown – FWB:TRB0 - TradingView
TRIB|Trinity Biotech PLC|Price:6.760|Chg%:-0.190 - TradingKey
Trinity Biotech plc (TRIB) stock price, news, quote and history - Yahoo Finance UK
Trinity Biotech Moves to One-for-Thirty ADS Reverse Split to Meet Nasdaq Bid Price Rules - The Globe and Mail
Trinity Biotech partners with Latch Medical on metabolic health tech - Investing.com
These stocks are moving in today's pre-market session - ChartMill
Trinity Biotech plans 1-for-30 reverse ADS split - Investing.com
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - Yahoo Finance
Trinity Biotech Plans Mandatory Exchange of 30 ADSs for 1 on July 24 - Stock Titan
Trinity Biotech Announces 1-for-30 Reverse ADS Split to Regain Nasdaq Compliance | TRIB Stock News - quiverquant.com
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology - The Manila Times
Trinity Biotech Plc Adr (TRIB) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
1.62%
大文字化:
|
ボリューム (24 時間):